Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9491949 | 1.00 | LMNA (0.44) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9492233 | 0.86 | LMNA (0.39) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9492241 | 0.86 | LMNA (0.39) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9494278 | 0.81 | LMNA (0.52) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9494274 | 0.81 | LMNA (0.52) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9494810 | 0.78 | RECQL (0.34) | LMNARECQLALDH1A1MAPTMAPK1 | |
| Phosphoric Acid SCHEMBL11090384 | 0.74 | LMNA (0.49) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9491882 | 0.73 | ALDH1A1 (0.40) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9491872 | 0.73 | LMNA (0.41) | LMNARECQLALDH1A1MAPTMAPK1 | |
| SCHEMBL9491876 | 0.73 | LMNA (0.41) | LMNARECQLALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494047-A1 | Use of carbazones for the treatment of rheumatoid diseases | CIBA-GEIGY AG (CH) | 1992-07-08 | — | — | EP | claimed |
| US-5177091-A | Rheumatic disorders | CIBA-GEIGY CORPORATION (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0494047-A1 | Use of carbazones for the treatment of rheumatoid diseases | CIBA-GEIGY AG (CH) | 1992-07-08 | — | — | EP | disclosed |